RNAi Technology Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global RNAi (Ribonucleic Acid Interference) technology market looks promising with opportunities in the drug discovery and development, and therapeutic applications. The global RNAi technology market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are rising genetic and metabolic disorder and increasing applications of RNAi technology in molecular diagnostics.
Emerging trends, which have a direct impact on the dynamics of the industry, include advancement in technologies such as small interfering RNA (siRNA) tolerant to nucleases and non-viral vectors, such as cationic liposomes and nanoparticles.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global RNAi technology market report, please download the report brochure.
The study includes trends and forecast for the global RNAi technology market by therapeutic area, application, and region as follows:
By Therapeutic Area [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that the oncology will remain the largest segment over the forecast period due to increasing prevalence of cancer and new product development in oncology segment such as small interfering RNA tolerant to nucleases and non-viral vectors, such as cationic liposomes and nanoparticles.
North America will remain the largest region over the forecast period due to increasing investment by biotechnology companies for RNAi therapeutic development in the region.
Features of the Global RNAi Technology Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global RNAi technology market by therapeutic area (oncology, ocular disorders, respiratory disorders, liver diseases, and neuronal disorders), application (drug discovery & development, therapeutics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global RNAi technology market?
Q.5 What are the business risks and threats to the global RNAi technology market?
Q.6 What are the emerging trends in this RNAi technology market and the reasons behind them?
Q.7 What are some changing demands of customers in this RNAi technology market?
Q.8 What are the new developments in this RNAi technology market? Which companies are leading these developments?
Q.9 Who are the major players in this RNAi technology market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this RNAi technology market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global RNAi technology market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Therapeutic Area (Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders) and Application (Drug Discovery & Development, Therapeutics, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global RNAi (Ribonucleic Acid Interference) technology market looks promising with opportunities in the drug discovery and development, and therapeutic applications. The global RNAi technology market is expected to grow with a CAGR of 7%-9% from 2020 to 2025. The major drivers for this market are rising genetic and metabolic disorder and increasing applications of RNAi technology in molecular diagnostics.
Emerging trends, which have a direct impact on the dynamics of the industry, include advancement in technologies such as small interfering RNA (siRNA) tolerant to nucleases and non-viral vectors, such as cationic liposomes and nanoparticles.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global RNAi technology market report, please download the report brochure.
The study includes trends and forecast for the global RNAi technology market by therapeutic area, application, and region as follows:
By Therapeutic Area [Value ($ Million) shipment analysis for 2014 – 2025]:
- Oncology
- Ocular Disorders
- Respiratory Disorders
- Liver Diseases
- Neuronal Disorders
- Drug Discovery & Development
- Therapeutics
- Others
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that the oncology will remain the largest segment over the forecast period due to increasing prevalence of cancer and new product development in oncology segment such as small interfering RNA tolerant to nucleases and non-viral vectors, such as cationic liposomes and nanoparticles.
North America will remain the largest region over the forecast period due to increasing investment by biotechnology companies for RNAi therapeutic development in the region.
Features of the Global RNAi Technology Market
- Market Size Estimates: Global RNAi technology market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global RNAi technology market size by various segments, such as therapeutic area and application in terms of value.
- Regional Analysis: Global RNAi technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different therapeutic area, application, and region for the global RNAi technology market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global RNAi technology market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global RNAi technology market by therapeutic area (oncology, ocular disorders, respiratory disorders, liver diseases, and neuronal disorders), application (drug discovery & development, therapeutics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global RNAi technology market?
Q.5 What are the business risks and threats to the global RNAi technology market?
Q.6 What are the emerging trends in this RNAi technology market and the reasons behind them?
Q.7 What are some changing demands of customers in this RNAi technology market?
Q.8 What are the new developments in this RNAi technology market? Which companies are leading these developments?
Q.9 Who are the major players in this RNAi technology market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this RNAi technology market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global RNAi technology market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Therapeutic Area (Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders) and Application (Drug Discovery & Development, Therapeutics, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global RNAi Technology Market Trends and Forecast
3.3: Global RNAi Technology Market by Therapeutic Area
3.3.1: Oncology
3.3.2: Ocular Disorders
3.3.3: Respiratory Disorders
3.3.4: Liver Diseases
3.3.5: Neuronal Disorders
3.4: Global RNAi Technology Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Therapeutics
3.4.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global RNAi Technology Market by Region
4.2: North American RNAi Technology Market
4.2.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.2.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.2.3: The United States RNAi Technology Market
4.2.4: The Canadian RNAi Technology Market
4.2.5: The Mexican RNAi Technology Market
4.3: European RNAi Technology Market
4.3.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.3.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.3.3: The RNAi Technology Market of United Kingdom
4.3.4: The German RNAi Technology Market
4.3.5: The French RNAi Technology Market
4.4: APAC RNAi Technology Market
4.4.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.4.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.4.3: The Chinese RNAi Technology Market
4.4.4: The Indian RNAi Technology Market
4.4.5: The Japanese RNAi Technology Market
4.5: ROW RNAi Technology Market
4.5.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.5.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.5.3: Brazilian RNAi Technology Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global RNAi Technology Market by Therapeutic Area
7.1.2: Growth Opportunities for the Global RNAi Technology Market by Application
7.1.3: Growth Opportunities for the Global RNAi Technology Market by Region
7.2: Emerging Trends in the Global RNAi Technology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global RNAi Technology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNAi Technology Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Affymetrix Inc.
8.2: Agilent Technologies Inc.
8.3: Bio-Rad Laboratories Inc.
8.4: GE Healthcare
8.5: Illumina Inc.
8.6: Qiagen N.V.
8.7: F. Hoffmann-La Roche Ltd.
8.8: Sigma Aldrich
8.9: Fluidigm Corporation
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global RNAi Technology Market Trends and Forecast
3.3: Global RNAi Technology Market by Therapeutic Area
3.3.1: Oncology
3.3.2: Ocular Disorders
3.3.3: Respiratory Disorders
3.3.4: Liver Diseases
3.3.5: Neuronal Disorders
3.4: Global RNAi Technology Market by Application
3.4.1: Drug Discovery & Development
3.4.2: Therapeutics
3.4.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global RNAi Technology Market by Region
4.2: North American RNAi Technology Market
4.2.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.2.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.2.3: The United States RNAi Technology Market
4.2.4: The Canadian RNAi Technology Market
4.2.5: The Mexican RNAi Technology Market
4.3: European RNAi Technology Market
4.3.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.3.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.3.3: The RNAi Technology Market of United Kingdom
4.3.4: The German RNAi Technology Market
4.3.5: The French RNAi Technology Market
4.4: APAC RNAi Technology Market
4.4.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.4.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.4.3: The Chinese RNAi Technology Market
4.4.4: The Indian RNAi Technology Market
4.4.5: The Japanese RNAi Technology Market
4.5: ROW RNAi Technology Market
4.5.1: Market by Therapeutic Area: Oncology, Ocular Disorders, Respiratory Disorders, Liver Diseases, and Neuronal Disorders
4.5.2: Market by Application: Drug Discovery & Development, Therapeutics, and Others
4.5.3: Brazilian RNAi Technology Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global RNAi Technology Market by Therapeutic Area
7.1.2: Growth Opportunities for the Global RNAi Technology Market by Application
7.1.3: Growth Opportunities for the Global RNAi Technology Market by Region
7.2: Emerging Trends in the Global RNAi Technology Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global RNAi Technology Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global RNAi Technology Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Affymetrix Inc.
8.2: Agilent Technologies Inc.
8.3: Bio-Rad Laboratories Inc.
8.4: GE Healthcare
8.5: Illumina Inc.
8.6: Qiagen N.V.
8.7: F. Hoffmann-La Roche Ltd.
8.8: Sigma Aldrich
8.9: Fluidigm Corporation
8.10: Company
